Hinge Health, Inc. (HNGE) insider buying and selling

NYSE: HNGE · Source: SEC Form 4 filings · Latest trade reported

In the last 90 days at Hinge Health, Inc. (HNGE), no insider made an open-market purchase and 6 insiders made 52 open-market sales worth $95.6M, as reported on SEC Form 4. 42 of the 52 sales were scheduled in advance or made to cover tax on vesting shares, so they say less about the insider's view of the stock. Over the last 12 months, 6 insiders sold $170.5M, of which $170.1M was scheduled or tax-related.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
52
$95.6M · 6 insiders
Insider buys, 12 months
0
$0 · 0 insiders
Insider sales, 12 months
133
$170.5M · 6 insiders

This is the public summary. Create a free account to see HNGE’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock HNGE

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at Hinge Health, Inc.
DateInsiderTypeSharesPriceValue
Elliott Robinson
Director
Open market sale
9 trades
0—$0
Kristina M Leslie
Director
Open market sale1,200$88.23$106K
Elliott Robinson
Director
Open market sale
3 trades
0—$0
Elliott Robinson
Director
Open market sale
2 trades
0—$0
Elliott Robinson
Director
Open market sale
2 trades
0—$0
Elliott Robinson
Director
Open market sale
4 trades
0—$0
Elliott Robinson
Director
Open market sale
3 trades
0—$0
Kristina M Leslie
Director
Open market sale
3 trades
7,250avg. $43.01$312K
Elliott Robinson
Director
Open market sale0—$0

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at Hinge Health, Inc.
DateInsiderTypeSharesPriceValue
Gabriel M.I. Mecklenburg
Director
10b5-1 sale
4 trades
200,000avg. $103.13$20.6M
James Budge
CFO
10b5-1 sale
4 trades
47,720avg. $103.13$4.9M
Daniel Antonio Perez
CEO
10b5-1 sale4,100$100.20$411K
James Pursley
President
10b5-1 sale
3 trades
33,000avg. $94.14$3.1M
Gabriel M.I. Mecklenburg
Director
10b5-1 sale
11 trades
400,000avg. $90.56$36.2M
Daniel Antonio Perez
CEO
10b5-1 sale
10 trades
250,000avg. $89.45$22.4M
James Budge
CFO
10b5-1 sale
5 trades
55,561avg. $89.45$5.0M
James Pursley
President
10b5-1 sale
4 trades
33,000avg. $88.05$2.9M

What the HNGE insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for Hinge Health, Inc. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with HNGE Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about HNGE insider trading

Who bought Hinge Health, Inc. (HNGE) stock recently?

No insider made an open-market purchase of Hinge Health, Inc. (HNGE) stock in the last 12 months.

Are insiders buying or selling HNGE?

Over the last 12 months insiders were net sellers of HNGE on discretionary trades: $0 bought against $418K sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see HNGE in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.